| CEO Name | Rajiv Gandhi |
| Nationality | India |
| Net Worth Estimation | $20 million |
Rajiv Gandhi, current CEO of Hester Biosciences, has an estimated net worth of around $20 million based on his significant equity stake in the company and accumulated executive compensation. Sources such as annual reports and market capitalization data support this valuation by outlining his shareholdings and earnings.
Rajiv Gandhi, CEO of Hester Biosciences, has an estimated net worth of $20,000,000, which is approximately 28.6% of the $70,000,000 maximum in the veterinary business category. His net worth is 20 times higher than the minimum estimated CEO net worth of $1,000,000 in this sector.
Business Category: Veterinary
Minimum Net Worth (estimation): 1000000 USD
Maximum Net Worth (estimation): 70000000 USD
Rajiv Gandhi Performance in Hester Biosciences
Rajiv Gandhi, CEO of Hester Biosciences, demonstrates strategic leadership and data-driven decision-making that have propelled the company's growth in animal healthcare. Under his tenure, Hester Biosciences has expanded its product portfolio and increased market share through innovation and efficient resource management. His focused leadership significantly enhanced the company's operational performance and industry reputation.
Latest News
Hester Biosciences CEO Rajiv Gandhi Drives Growth and Expansion
Hester Biosciences, led by CEO and MD Rajiv Gandhi, reported a near three-fold profit surge in late 2024, driven by foreign exchange gains and growth in poultry and pet care segments. The company is expanding internationally with vaccine plants in Nepal and Africa and is developing new poultry vaccines like Avian Influenza, aiming to strengthen its market presence.
Source: http://www.business-standard.com/topic/hester-biosciences